Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Calyxha Biotechnologies logo — A new perspective on inflammation

Calyxha Biotechnologies

A new perspective on inflammation

Founded 2019 Austria Austria 2 employees Seed Total: $1.00M Biotechnology

General Information

Company Name Calyxha Biotechnologies
Founded Year 2019
Location Austria Austria +1
Employees 2
Industries Biotechnology
Funding Stage Seed
Social

Get notified when Calyxha Biotechnologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Calyxha Biotechnologies

Calyxha Biotechnologies is a biotech startup based in Austria that is focused on revolutionizing the treatment of inflammation. Established in 2019, the company's slogan "A new perspective on inflammation" encapsulates their mission to bring innovative solutions to the field. Specializing in the development of novel small molecule anti-inflammatory drugs, Calyxha has attracted the attention of investors. In February 2020, Calyxha successfully secured a notable €1.00M Seed Round investment from Arax Capital Partners and Kinled Holding. This funding signifies a strong vote of confidence from renowned investment entities in Calyxha's potential. With this injection of capital, Calyxha is well-positioned to accelerate its research and development efforts and advance toward bringing its breakthrough treatments to market. The company's ability to attract investment reflects the promising trajectory of their groundbreaking research and the potential impact of their innovations in the field of biotechnology. Calyxha Biotechnologies stands at the forefront of addressing a critical medical need, and their progress in securing funding underscores the industry's recognition of their vision and capabilities. As the company continues to advance its developments, its collaboration with respected investment partners provides a solid foundation for driving future success in the critical area of anti-inflammatory therapeutics.

Taxonomy: biotech company, small molecule drugs, anti-inflammatory, drug discovery, pharmaceuticals, biomedical research, inflammation treatment

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
28 Feb 2020

FAQ About Calyxha Biotechnologies

A new perspective on inflammation
Calyxha Biotechnologies was founded in 2019.
Calyxha Biotechnologies is headquartered in Austria.
Calyxha Biotechnologies operates in the following industries: Biotechnology.
Calyxha Biotechnologies has approximately 2 employees.
Calyxha Biotechnologies has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Seed.

We're actively collecting intelligence on Calyxha Biotechnologies.

Track Calyxha Biotechnologies to get notified

Don't just browse. Track.

Signal Tracker monitors Calyxha Biotechnologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes